De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients (clinicaltrials.gov) - Jan 9, 2026 - P3 | N=60 | Active, not recruiting | Sponsor: Virginia Commonwealth University | Recruiting ➔ Active, not recruiting | Trial primary completion date: Dec 2025 ➔ Mar 2026
Enrollment closed • Trial primary completion date • Cytomegalovirus Infection • Transplantation • CYP3A5
|